Mallory Morales
Directeur Financier/CFO chez IMMUNEERING CORPORATION
Fortune : 11 838 $ au 30/04/2024
Postes actifs de Mallory Morales
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNEERING CORPORATION | Comptroller/Controller/Auditor | 10/08/2022 | - |
| Directeur Financier/CFO | 10/08/2022 | - | |
| Treasurer | 10/08/2022 | - | |
| Corporate Officer/Principal | 01/05/2021 | 10/08/2022 |
Historique de carrière de Mallory Morales
Anciens postes connus de Mallory Morales
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/10/2020 | 01/05/2021 |
| IMMUNOMEDICS, INC. | Directeur/Membre du Conseil | 01/04/2018 | 01/10/2020 |
| Corporate Officer/Principal | 01/04/2018 | 01/10/2020 | |
| L'ORÉAL | Directeur Financier/CFO | 01/05/2014 | 01/04/2018 |
Formation de Mallory Morales
| State University of New York at Albany | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| France | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
| Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| L'ORÉAL | Consumer Non-Durables |
| Entreprise privées | 1 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
- Bourse
- Insiders
- Mallory Morales
- Expérience
